Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events - Additional Information (Details)

v3.21.2
Subsequent Events - Additional Information (Details)
$ in Millions
3 Months Ended
Jul. 15, 2021
Sep. 30, 2021
USD ($)
location
Sun Clinical Laboratories | Forecast    
Subsequent Event [Line Items]    
Interest acquired   49.00%
Consideration transferred | $   $ 4.0
Number of locations | location   19
Subsequent Event | Access Primary Care Medical Group    
Subsequent Event [Line Items]    
Business combination, percentage paid In cash within ten business days 50.00%  
Business combination, percentage paid out in cash upon achievement of financial milestones 50.00%  
Interest acquired 80.00%